Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
An adapted clinical global Impression of improvement for use in Angelman syndrome: Validation analyses utilizing data from the NEPTUNE study.
Journal: European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
Published: April 11, 2023
Gaboxadol in angelman syndrome: A double-blind, parallel-group, randomized placebo-controlled phase 3 study.
Journal: European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
Published: April 11, 2023
Enabling endpoint development for interventional clinical trials in individuals with Angelman syndrome: a prospective, longitudinal, observational clinical study (FREESIAS).
Journal: Journal of neurodevelopmental disorders
Published: January 17, 2023
Health-related quality of life and medication use among individuals with Angelman syndrome.
Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
Published: December 12, 2022
Cross-Sectional Exploration of Plasma Biomarkers of Alzheimer's Disease in Down Syndrome: Early Data from the Longitudinal Investigation for Enhancing Down Syndrome Research (LIFE-DSR) Study.
Journal: Journal of clinical medicine
Published: March 27, 2021
The STARS Phase 2 Study: A Randomized Controlled Trial of Gaboxadol in Angelman Syndrome.
Journal: Neurology
Published: March 03, 2020
Screening school-age children for developmental language disorder in primary care.
Journal: International journal of speech-language pathology
Published: July 03, 2019
Pharmacological interventions to improve cognition and adaptive functioning in Down syndrome: Strides to date.
Journal: American journal of medical genetics. Part A
Published: December 23, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026